Raymond James & Associates’s Leonardo DRS DRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$687K Sell
24,359
-1,265
-5% -$34.7K ﹤0.01% 2916
2024
Q2
$654K Buy
25,624
+2,747
+12% +$62.9K ﹤0.01% 2898
2024
Q1
$505K Buy
22,877
+5,343
+30% +$111K ﹤0.01% 3059
2023
Q4
$351K Sell
17,534
-3,313
-16% -$62.5K ﹤0.01% 3181
2023
Q3
$348K Buy
20,847
+510
+3% +$8.61K ﹤0.01% 3105
2023
Q2
$353K Buy
20,337
+446
+2% +$6.9K ﹤0.01% 3144
2023
Q1
$258K Sell
19,891
-701
-3% -$9.06K ﹤0.01% 3339
2022
Q4
$263K Buy
+20,592
New +$239K ﹤0.01% 3295

Other funds holding DRS

Raymond James & Associates's DRS Position: Q3 2024 in Review

Raymond James & Associates reduced its Leonardo DRS (DRS) stake by 4.9% in Q3 2024, selling an estimated $34.7K and leaving 24,359 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

Raymond James & Associates first reported a position in DRS in Q4 2022 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold DRS as of Q3 2024.

  • Raymond James & Associates held 24,359 shares of Leonardo DRS worth $687K as of Q3 2024.
  • Raymond James & Associates sold 1,265 Leonardo DRS shares in Q3 2024, an estimated $34.7K.
  • Leonardo DRS made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2916 holding.
  • Raymond James & Associates first reported a position in Leonardo DRS in Q4 2022 and has held it in 8 quarters since.
  • 212 funds tracked by Wall St. Rank held Leonardo DRS as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.